MedTrace Logo

A Study of Retrograde rEperfusion in Dbd Donor LIver Transplantation

NCT02423941 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2017-01-04

No results posted yet for this study

Summary

To evaluate whether retrograde caval reperfusion of liver graft could be superior over antegrade portal reperfusion in regard of incidence and severity of early allograft liver dysfunction.

All eligible enrolled liver transplant candidates will be randomized to receive either:

1. retrograde caval, followed by sequential portal-arterial, reperfusion or
2. antegrade, sequential portal-arterial reperfusion.

Conditions

  • Liver Transplantation
  • Reperfusion
  • Delayed Graft Function

Interventions

PROCEDURE

Retrogade reperfusion

Retrogade caval reperfusion of the donor liver during the transplant procedure with consequent arterial reperfusion.

PROCEDURE

Antegrade reperfusion

Antegrade conventional portal reperfusion of the donor liver during the transplant procedure with consequent arterial reperfusion.

Sponsors & Collaborators

  • Republican Scientific and Practical Center for Organ and Tissue Transplantation

    lead OTHER

Principal Investigators

  • Oleg O Rummo, MD PhD · RSPC for organ and tissue transplantation, Minsk 9th clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-01-31
Completion
2017-05-31

Countries

  • Belarus

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02423941 on ClinicalTrials.gov